Related Experiment Video
Updated: Jun 18, 2026

Examination of Thymic Positive and Negative Selection by Flow Cytometry
Published on: October 8, 2012
Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad
Anna Frenzel1, Verena Labi, Waldemar Chmelewskij
1Division of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Abstract:
Oncogenic c-Myc is known to balance excessive proliferation by apoptosis that can be triggered by p53-dependent and p53-independent signaling networks. Here, we provide evidence that the BH3-only proapoptotic Bcl-2 family members Bcl-2 modifying factor (Bmf) and Bcl-2 antagonist of cell death (Bad) are potent antagonists of c-Myc-driven B-cell lymphomagenesis. Tumor formation was preceded by the accumulation of preneoplastic pre-B and immature immunoglobulin M-positive (IgM(+)) B cells in hematopoietic organs of Emu-myc/bmf(-/-) mice, whereas Emu-myc/bad(-/-) mice showed an increase of pre-B cells limited to the spleen. Although the loss of Bad had no impact on the tumor immunophenotype, Bmf deficiency favored the development of IgM(+) B cell over pre-B cell tumors. This phenomenon was caused by a strong protection of immature IgM(+) B cells from oncogene-driven apoptosis caused by loss of bmf and c-Myc-induced repression of Bmf expression in premalignant pre-B cells. Steady-state levels of B-cell apoptosis also were reduced in the absence of Bad, in support of its role as a sentinel for trophic factor-deprivation. Loss of Bmf reduced the pressure to inactivate p53, whereas Bad deficiency did not, identifying Bmf as a novel component of the p53-independent tumor suppressor pathway triggered by c-Myc.
Insights
Bcl-2 modifying factor (Bmf) and Bcl-2 antagonist of cell death (Bad) proteins suppress c-Myc-driven B-cell lymphomagenesis. Loss of Bmf, but not Bad, promotes B-cell lymphoma by inhibiting apoptosis.
Area of Science:
- Molecular Biology
- Cancer Biology
- Immunology
Background:
- Oncogenic c-Myc drives excessive cell proliferation balanced by apoptosis via p53-dependent and -independent pathways.
- BH3-only proapoptotic Bcl-2 family members, including Bmf and Bad, are key regulators of apoptosis.
Purpose of the Study:
- To investigate the roles of Bmf and Bad in antagonizing c-Myc-driven B-cell lymphomagenesis.
- To elucidate the mechanisms by which Bmf and Bad influence tumor development and apoptosis.
Main Methods:
- Utilized Emu-myc transgenic mice lacking Bmf or Bad.
- Analyzed tumor formation, cell accumulation in hematopoietic organs, and immunophenotypes.
- Assessed B-cell apoptosis and p53 pathway activation.
Main Results:
- Bmf and Bad antagonize c-Myc-driven B-cell lymphomagenesis.
- Loss of Bmf, but not Bad, promoted IgM(+) B-cell lymphoma by protecting against oncogene-induced apoptosis.
- Bmf deficiency reduced the need for p53 inactivation, implicating it in a p53-independent pathway.
Conclusions:
- Bmf and Bad are critical suppressors of c-Myc-driven B-cell lymphomagenesis.
- Bmf acts as a p53-independent tumor suppressor by maintaining apoptosis in pre-malignant B cells.
- Bad functions as a sentinel for trophic factor deprivation, impacting B-cell apoptosis levels.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Negative Regulator Molecules
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

